| The value of health insurance: the access motive JA Nyman Journal of health economics 18 (2), 141-152, 1999 | 402 | 1999 |
| The theory of demand for health insurance JA Nyman Stanford University Press, 2003 | 343 | 2003 |
| The economics of moral hazard revisited JA Nyman Journal of health economics 18 (6), 811-824, 1999 | 254 | 1999 |
| Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection GA Filice, JA Nyman, C Lexau, CH Lees, LA Bockstedt, K Como-Sabetti, ... Infection Control & Hospital Epidemiology 31 (4), 365-373, 2010 | 251 | 2010 |
| Profit incentives and technical efficiency in the production of nursing home care JA Nyman, DL Bricker The Review of Economics and Statistics, 586-594, 1989 | 228 | 1989 |
| Excess demand, the percentage of Medicaid patients, and the quality of nursing home care JA Nyman Journal of Human Resources, 76-92, 1988 | 223 | 1988 |
| Mindfulness-based stress reduction for solid organ transplant recipients: a randomized controlled trial CR Gross, MJ Kreitzer, W Thomas, M Reilly-Spong, ... Alternative therapies in health and medicine 16 (5), 30, 2010 | 217 | 2010 |
| Prospective and ‘cost-plus’ Medicaid reimbursement, excess Medicaid demand, and the quality of nursing home care JA Nyman Journal of Health Economics 4 (3), 237-259, 1985 | 203 | 1985 |
| Improving diabetes care in practice: findings from the TRANSLATE trial KA Peterson, DM Radosevich, PJ O'Connor, JA Nyman, RJ Prineas, ... Diabetes care 31 (12), 2238-2243, 2008 | 166 | 2008 |
| Is ‘moral hazard’inefficient? The policy implications of a new theory JA Nyman Health Affairs 23 (5), 194-199, 2004 | 165 | 2004 |
| Assessment of optimal size and composition of the US National Registry of hematopoietic stem cell donors C Kollman, E Abella, RL Baitty, PG Beatty, R Chakraborty, ... Transplantation 78 (1), 89-95, 2004 | 156 | 2004 |
| Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women JT Schousboe, JA Nyman, RL Kane, KE Ensrud Annals of internal medicine 142 (9), 734-741, 2005 | 151 | 2005 |
| Improving the quality of nursing home outcomes: Are adequacy-or incentive-oriented policies more effective? JA Nyman Medical Care 26 (12), 1158-1171, 1988 | 149 | 1988 |
| Should the consumption of survivors be included as a cost in cost–utility analysis? JA Nyman Health economics 13 (5), 417-427, 2004 | 132 | 2004 |
| Analysis of nursing home use and bed supply: Wisconsin, 1983. JA Nyman Health Services Research 24 (4), 511, 1989 | 114 | 1989 |
| The effect of competition on nursing home expenditures under prospective reimbursement. JA Nyman Health Services Research 23 (4), 555, 1988 | 113 | 1988 |
| Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics JA Nyman, NA Barleen, BE Dowd, DW Russell, SJ Coons, PW Sullivan Medical care 45 (7), 618-628, 2007 | 109 | 2007 |
| The effects of market concentration and excess demand on the price of nursing home care JA Nyman The Journal of Industrial Economics, 193-204, 1994 | 109 | 1994 |
| The private demand for nursing home care JA Nyman Journal of Health Economics 8 (2), 209-231, 1989 | 102 | 1989 |
| Technical efficiency in nursing homes JA Nyman, DL Bricker, D Link Medical Care 28 (6), 541-551, 1990 | 100 | 1990 |
